Cita APA

Sargis, R. M., & Salgia, R. (2015). Multiple Endocrine Disruption by the MET/ALK Inhibitor Crizotinib in Patients With Non–Small Cell Lung Cancer.

Chicago Style Citation

Sargis, Robert M., i Ravi Salgia. Multiple Endocrine Disruption By the MET/ALK Inhibitor Crizotinib in Patients With Non–Small Cell Lung Cancer. 2015.

Cita MLA

Sargis, Robert M., i Ravi Salgia. Multiple Endocrine Disruption By the MET/ALK Inhibitor Crizotinib in Patients With Non–Small Cell Lung Cancer. 2015.